Streetbeat News

Partnerships

PCRX

The American Society of Anesthesiologists (ASA) and Pacira BioSciences, Inc. (NASDAQ:PCRX) have announced a new grant of $2.5 million by Pacira to the ASA Charitable Foundation. The grant aims to advance the medical specialty of anesthesiology and pain medicine, facilitate clinician education, and improve patient care.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 12:15 pm

PARA

TSX:TOY

Spin Master Corp. (TSX:TOY) has secured a global toy license for the upcoming Paramount+ original preschool series, Dora. The toy collection, inspired by the Dora the Explorer franchise, is expected to launch in Fall 2024. The series will stream exclusively on Paramount+ in Spring 2024 in the U.S. and internationally on Paramount+ and Nickelodeon channels.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 12:08 pm

SYTA

Siyata Mobile Inc. (SYTA) has partnered with Consort Digital PTE Ltd. to offer its MCX ONE Push-to-Talk application on Siyata's SD7 handset. The companies are already pursuing business together by responding to large-scale procurement opportunities with Consort Digital's Push-to-Talk application, and Siyata's SD7 handset.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 12:07 pm

PLSE

Pulse Biosciences has announced a collaboration with CardioNXT for a first-in-human atrial fibrillation study using non-thermal pulsed field ablation (nsPFA).

Portfolio Pulse from Bill Haddad

October 02, 2023 | 12:05 pm

V

Visa (NYSE:V) has announced a strategic partnership with Expel, a security operations provider, to enhance its Value-Added Services offering in the Managed Detection and Response (MDR) segment. The partnership aims to help Visa's clients anticipate and protect against cyber threats. Expel's MDR capabilities will prioritize detections based on clients' key assets, reduce alert-to-response time, and stop threats from spreading. Initially, Visa will offer Expel's solution to its clients in the United States and Canada, with plans for a global rollout.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 12:03 pm

RXRX

Recursion Pharmaceuticals announced that Roche has exercised the validated small molecule option in a single area of oncology under their collaboration and license agreement. Roche will pay an option fee as per the agreement dated December 5, 2021.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 11:58 am

EVO

Iama Therapeutics has signed a multi-phase agreement with Evotec. Under the agreement, Evotec will provide preclinical and clinical services to support IAMA's Phase 1 clinical trial for its lead program IAMA-6, a therapeutic targeting NKCC1 for the treatment of autism and epilepsy.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 11:46 am

SHYF

Shyft Group (SHYF) has finalized an agreement with Rush Enterprises to sell and service Shyft's Blue Arc Class 3, 4, and 5 all-electric delivery vehicles. This partnership is expected to expand Shyft's reach and potentially increase its revenues.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 11:41 am

ARAY

Accuray Incorporated (ARAY) and Limbus AI have unveiled an online adaptive therapy solution for the Radixact System at the American Society for Radiation Oncology Annual Meeting. This solution is expected to enhance the precision and efficiency of radiation therapy treatments.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2023 | 11:40 am

DISH

The Federal Communications Commission (FCC) has confirmed that DISH Network has met its band-specific and two out of three nationwide 5G commitments set for June 14, 2023.

Portfolio Pulse from Charles Gross

October 02, 2023 | 11:38 am